Calcium carbonate/Aspirin/Calcitriol

碳酸钙/阿司匹林/骨化三醇

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCalcium carbonate/Aspirin/Calcitriol

Drug Alias NameAspirin/1alpha-25-dihydroxycholecalciferol/Calcium carbonateAcetylsalicylic acid/1alpha-25-dihydroxycholecalciferol/Calcium carbonate

ClassificationSmall molecules

Mechanisms of ActionCyclooxygenases inhibitorsVitamin D receptor antagonistsBone development modulators

TargetsVitamin D receptorCyclooxygenases

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAllergan Plc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAllergan Plc

Active IndicationsN/A

Inactive IndicationsColorectal Neoplasms

ATC CodeN/A